PMDD in India: Symptoms, Diagnosis and Treatment

• PMDD is a recognised DSM-5 depressive disorder affecting roughly 3 to 8 percent of women — severe, cyclical, and dominated by mood symptoms, not just physical ones.
• The defining feature is timing: symptoms appear in the luteal phase (the two weeks before a period), lift within 2 to 3 days of bleeding, and return every cycle.
• There is no blood test. Diagnosis rests on a prospective daily symptom diary kept across two to three cycles, plus a work-up to rule out thyroid, anaemia and depression.
• Treatment works well: lifestyle changes first, then CBT, SSRIs (continuous or luteal-only dosing) and drospirenone-containing pills in selected women.
• Suicidal thoughts or self-harm urges in the premenstrual week are a medical emergency — call Telemanas 14416 or 112 and do not stay alone.

PMS and PMDD share the same trigger — the falling estrogen and progesterone of the luteal phase — and the same timing in the cycle, which is why the two are so often confused. The difference lies in severity, functional impact and diagnostic classification.

PMS is common (roughly three in four women), mostly physical (bloating, breast tenderness, fatigue, food cravings) with some mood symptoms (irritability, mild low mood). It is manageable with self-care and never quite tips into clinical depression criteria. If most of what you notice is irritability and a short fuse that you can still ride out, that is closer to ordinary premenstrual mood change.

PMDD is uncommon (3 to 8 percent of women), severe, and dominated by psychological symptoms — deep sadness or hopelessness, marked anxiety, sharp mood swings, persistent anger, feeling out of control — alongside the physical ones. It meets the criteria for clinical depression during the luteal phase, lifts within two to three days of the period starting, and returns in the next cycle. It is this cyclical, predictable, severe-then-better-then-severe-again pattern that distinguishes PMDD from major depression or generalised anxiety disorder. The link between hormones and mental health is real and biological, not imagined.

The third clue is functional impact. PMS is a week of mild inconvenience that work and relationships absorb. PMDD reshapes the luteal week — missed deadlines, work mistakes, fights with a partner or children, withdrawal from friends, in severe cases self-harm urges or suicidal thoughts — and then lifts as the period starts. If the same pattern of disability repeats two or three months in a row in the luteal phase only, the right next step is a psychiatric assessment for PMDD.

PMDD has a very specific, reproducible time signature. Symptoms begin in the luteal phase — the second half of the cycle, roughly from ovulation around day 14 to the start of the next period — and peak in the final 5 to 7 days before the bleed. They lift sharply once the period starts, usually within 2 to 3 days, and the woman is symptom-free or close to it during the follicular phase (from the end of the period to ovulation). The next cycle repeats the same pattern. Understanding what ovulation actually means helps make sense of why the second half of the cycle is the vulnerable window.

This luteal-only pattern is what separates PMDD from depression and anxiety disorders, which are present most of the time and not driven by the cycle. It is also why the daily symptom diary is so central: only a two-to-three-cycle diary that maps mood, anxiety, anger, fatigue and physical symptoms day by day can confirm the cyclical pattern PMDD requires. A woman who is low for three weeks and a little worse in the fourth probably has depression with premenstrual worsening; a woman who is well for two weeks and disabled in the next two has the PMDD pattern. Seeing your own emotions move with the cycle is something hormonal emotional waves describes well.

Three real-world implications follow. First, tracking matters more than memory — most women under-report the well weeks and over-report the bad ones because the contrast is so dramatic, which is why tracking your cycle without shame is a genuinely useful first step. Second, partners and family often see the pattern before the woman does. Third, the same hormonal trigger means PMDD tends to flare around any event that disrupts the cycle — postpartum, perimenopause, or stopping and starting hormonal contraception — and it does not simply go away with age or after childbirth.

• Severe sadness or hopelessness — a deep low mood that goes well beyond ordinary disappointment and that the woman recognises as out of character and out of proportion.
• Marked anxiety or tension — restlessness, a sense of being on edge, racing thoughts and a feeling of impending dread without a specific trigger.
• Marked mood swings and crying spells — sudden shifts from sad to angry to tearful within hours, often without an external trigger, and crying that feels uncontrollable.
• Persistent anger or irritability and increased interpersonal conflict — a short fuse, snapping at partner, children or colleagues, with fights she would not have started in the follicular phase.
• Lack of interest in usual activities — work, hobbies, friendships and sex feel flat and pointless for the luteal week, then re-engage as the period starts.
• Difficulty concentrating, brain fog and indecision — mistakes at work, forgotten appointments, an inability to follow a meeting or finish a familiar task.
• Fatigue and low energy — tiredness that sleep does not refresh, often described as bone-deep heaviness or moving through treacle.
• Appetite changes — strong cravings (often for carbohydrates, sweets or salty food) or binging episodes, and sometimes the opposite of reduced appetite.
• Sleep disturbance — insomnia, frequent night waking or, less commonly, sleeping much more than usual without feeling rested.
• Feeling overwhelmed or out of control — a sense that ordinary demands are unmanageable and that one cannot trust one's own reactions.
• Physical symptoms — breast tenderness, bloating, joint or muscle pain, headache, weight gain and a feeling of being puffy or swollen.
• Diagnosis requires at least five of the above during the luteal phase of most cycles in the previous year, with at least one being a mood symptom, confirmed by a prospective two-to-three-cycle daily diary.

There is no blood test or scan for PMDD. The diagnosis rests on a careful history and a prospective daily symptom diary kept across two to three menstrual cycles. The diary is non-negotiable because the same symptoms — sadness, anxiety, anger, fatigue — are also features of depression, anxiety, thyroid dysfunction and several other conditions, and only the cyclical luteal-only pattern distinguishes PMDD from them.

A simple, usable diary rates four to six symptoms (mood, anxiety, irritability, energy, sleep, physical) on a 0 to 3 scale each evening, alongside the day of the cycle. The validated Daily Record of Severity of Problems (DRSP) is widely used and can be downloaded as a PDF or kept inside a tracking app — the SHELY mood journal method is built for exactly this. Two clean cycles in which symptoms are clearly worse in the luteal week than in the follicular weeks, and which lift within 2 to 3 days of the period, are usually enough for a confident diagnosis.

The clinician — usually a gynecologist with mental-health interest or a psychiatrist — then adds a baseline work-up to rule out look-alike conditions. TSH (thyroid), CBC (anaemia), vitamin D, vitamin B12, prolactin and sometimes a depression screening tool such as PHQ-9 are commonly done; a pregnancy test is taken if relevant. Thyroid and anaemia in particular can mimic the fatigue and low mood of PMDD, so they are worth excluding. Once look-alikes are ruled out and the diary confirms the cyclical pattern, the diagnosis is made on DSM-5 criteria and a treatment plan is built jointly with the woman — almost always starting with lifestyle changes and, depending on severity, adding therapy and medication in parallel.

PMDD is widely under-recognised in India for a stack of overlapping reasons. The first is awareness — among women and general practitioners alike. PMDD does not feature in routine teaching to the same depth as PMS or depression, the lay press rarely covers it, and most women have simply never heard the term.

The second is cultural framing. The luteal-week symptoms are often dismissed at home as drama, attention-seeking or 'her usual hormones'; in older women they get relabelled as early menopause, in younger women as just bad PMS. Quiet, private support during the premenstrual week helps far more than judgement.

The third is the shortage of trained clinicians who actively look for PMDD, ask about cycle-related mood patterns, or hand over a daily diary. Many women who reach a doctor with mood symptoms get assessed for general depression or anxiety and prescribed a continuous SSRI that helps partially but misses the cyclical optimisation PMDD-specific care offers. The fourth is the cost-and-time barrier of repeated visits. The fifth is the suicidality risk itself — women in a bad week often hide the worst symptoms out of shame or fear of hospitalisation.

The clinical consequence is that many Indian women live with untreated PMDD that drives recurrent conflict, parenting strain, missed work and, in the most severe weeks, suicidal thoughts. The good news is that PMDD responds very well to treatment once it is correctly diagnosed. The opening move is simple: learn the term, track the cycle for two to three months, and take the diary to a gynecologist or psychiatrist willing to look at it. If you have been dismissed before, our guide on what to do when doctors don't listen can help you advocate for a proper assessment.

• Regular aerobic exercise — 30 minutes of brisk walking, cycling, swimming or dance most days improves mood and reduces anxiety and PMDD symptom severity; the effect is biological (endorphin and serotonin) as well as behavioural. Cycle-aware movement and gentle yoga and pranayama help in the luteal week.
• Reduce caffeine, alcohol and refined sugar — caffeine amplifies anxiety, alcohol disrupts sleep and worsens next-day mood, and refined-sugar spikes drive irritability and energy crashes; aim for under 200 mg caffeine per day in the luteal week and limit alcohol to occasional.
• Calcium 1,200 mg and vitamin D — the best-studied supplement combination for PMS and mild PMDD; aim for calcium-rich foods (milk, curd, paneer, ragi, sesame) plus a supplement if dietary intake is low, with vitamin D titrated to a serum level above 30 ng/mL.
• Magnesium 200 to 400 mg daily — may reduce bloating, breast tenderness, fatigue and mood symptoms; magnesium glycinate or citrate are usually better tolerated than oxide; food sources include leafy greens, nuts, seeds and whole grains.
• Vitamin B6 50 to 100 mg daily — modest evidence for reducing premenstrual mood symptoms; cap at 100 mg per day because higher doses can cause peripheral nerve symptoms with long-term use.
• Stress management — daily yoga, pranayama, meditation, journaling or guided breathing reduce luteal-week symptom intensity; protecting attention with a digital detox during PMS helps too.
• Adequate sleep — 7 to 9 hours per night with a consistent bedtime; protect sleep in the luteal week by reducing screen time after 9 pm and avoiding late caffeine.
• Track and plan around the cycle — schedule demanding meetings, difficult conversations and high-stakes decisions in the follicular phase, and protect the luteal week with lighter loads, lower expectations and more rest.

Cognitive behavioural therapy (CBT) is the most evidence-based talk therapy for PMDD, typically delivered as a structured 8 to 12 session course with a clinical psychologist. CBT does not change the hormonal trigger, but it changes how the woman thinks about and responds to luteal-week symptoms, which dramatically reduces functional disability. Sessions usually work on three threads: re-framing catastrophic thoughts that appear only in the luteal week ('my marriage is ending', 'I will lose my job'), behavioural activation to keep doing essential and rewarding activities even when motivation drops, and communication skills for the luteal week (pausing before responding, naming the symptom rather than blaming the person). It can also help prevent the slide into emotional burnout.

Couples therapy, or a single joint session with the partner, is often added because the conflict PMDD generates in the luteal week is one of its biggest functional impacts. A short course teaches the partner to recognise the pattern, not take cycle-driven anger personally, and provide structured support rather than escalate. CBT for the woman plus one to three educational sessions for the partner often delivers more functional improvement than medication alone.

In India CBT is available in person in most large cities (₹1,000 to ₹3,500 per session in private practice) and online through platforms such as Amaha (formerly InnerHour), YourDOST and Sahaj for a fraction of the cost. Government tertiary centres including NIMHANS Bangalore and the AIIMS Department of Psychiatry offer subsidised therapy with longer waiting lists. eSanjeevani, the government telemedicine platform, offers free first-line consultation that can refer on to CBT and medication where needed.

Selective serotonin reuptake inhibitors (SSRIs) are the first-line medication for moderate to severe PMDD, with a strong evidence base across many randomised trials. Two are particularly well studied: sertraline (Daxid, Zoloft) at 25 to 100 mg daily and fluoxetine (Prozac, Fludac) at 20 mg daily; escitalopram and paroxetine are also used. Unlike in depression, where SSRIs take 4 to 6 weeks to work, in PMDD they often help within the first one to two cycles.

There are two dosing strategies. Continuous dosing means taking the SSRI every day; this gives the steadiest control and is preferred when symptoms extend beyond the luteal week or when a luteal-only schedule is hard to keep. Luteal-only dosing means starting the SSRI around day 14 (at ovulation) and stopping on day one of the next period; this works particularly well for sertraline and fluoxetine, exposes the woman to medication for only half the month, and is often preferred when symptoms are tightly confined to the luteal phase.

Side effects are usually mild and settle within two weeks: nausea, headache, sleep disturbance and reduced libido are commonest. Indian generics make this affordable — sertraline 50 mg costs roughly ₹100 to ₹300 a month and fluoxetine 20 mg ₹100 to ₹250 a month at most chemists. SSRIs must be prescribed and monitored by a psychiatrist or a gynecologist with mental-health training; they are not for self-medication. Other options a doctor may consider include combined oral contraceptives in selected women (next section), spironolactone (Aldactone) 50 to 100 mg daily when fluid retention and breast tenderness dominate, and — in rare, severe, treatment-resistant cases — GnRH agonist therapy with add-back estrogen-progestin under specialist supervision.

Combined oral contraceptive pills can help PMDD in some women by suppressing ovulation and flattening the hormonal swings that drive symptoms. The evidence is strongest for combined pills containing drospirenone (Yaz, Yasmin, Yasminelle), particularly when taken continuously (skipping the placebo week) or in a 24/4 regimen rather than the standard 21/7. Drospirenone has mild diuretic and anti-androgen effects that seem to help mood-related and physical PMDD symptoms specifically. For a broader picture of the options, see our guide to birth control pills in India.

Two practical points matter. First, the response is variable: some women find drospirenone-containing pills dramatically helpful, while others find any combined pill worsens mood or causes its own side effects. The honest expectation is a three-cycle trial with continued diary tracking to see whether it works for the individual. Second, the pill is not first line for women with a personal history of major depression, bipolar disorder or migraine with aura — where the SSRI route is usually preferred and where some combined pills are contraindicated. If you also get menstrual migraine, flag it before any pill is started.

In India, drospirenone-containing pills cost ₹250 to ₹600 a month under brands such as Yamini, Krimson and Yaz; standard combined pills (Mala-D, Triquilar) are options too, though without the same PMDD-specific evidence. As with SSRIs, the pill needs a prescription and screening for the usual contraindications (smoking over 35, history of clot, uncontrolled blood pressure, migraine with aura). For some women the eventual answer is a combined pill plus a low-dose SSRI; for others, lifestyle plus CBT is enough. The diary and the woman together arrive at the right answer.

• Telemanas — 14416 (or 1-800-891-4416) — the Ministry of Health and Family Welfare's free 24x7 tele mental-health service in 20 Indian languages, with onward referral into the public mental-health system.
• iCall — 9152987821 — free, confidential phone, email and chat counselling run by TISS Mumbai, 8 am to 10 pm Monday to Saturday, multilingual including Hindi, English, Marathi and several South Indian languages.
• Vandrevala Foundation Helpline — 1860-266-2345 — free 24x7 confidential mental-health helpline with trained counsellors and onward referral to psychiatrists where needed.
• KIRAN Mental Health Helpline — 1800-599-0019 — Ministry of Social Justice and Empowerment 24x7 toll-free helpline in 13 Indian languages.
• NIMHANS Bangalore — 080-46110007 — the National Institute of Mental Health and Neurosciences runs a helpline alongside out-patient services and is one of India's most specialised centres for women's mental health.
• AIIMS New Delhi — the Department of Psychiatry offers specialist assessment of PMDD and other women's mental-health conditions; appointments through the AIIMS OPD booking system.
• eSanjeevani — the government national telemedicine service offers free telepsychiatry consultations; a useful first step where in-person psychiatrists are scarce.
• Private online platforms — Amaha (formerly InnerHour), Practo and YourDOST offer paid online therapy and psychiatrist consultations at predictable per-session fees, useful when privacy or scheduling matters.

• Suicidal thoughts with a plan, a method or a timeline — call Telemanas 14416 or the national emergency number 112 the same hour and go to the nearest hospital emergency department with a family member.
• Strong urges to self-harm (cutting, burning, overdose) — call Vandrevala 1860-266-2345 or iCall 9152987821 immediately and arrange a same-day psychiatric assessment; remove easy access to medication, sharps and other means until the luteal week passes and a plan is in place.
• Severe depressive symptoms — inability to get out of bed for two or more days, inability to eat or care for children, complete loss of interest in everything — arrange same-day psychiatric assessment, in person if available or via eSanjeevani if not.
• Complete inability to function — several days of missed work, escalating fights with a partner, children frightened by mood swings — bring forward the next gynecology or psychiatry appointment and discuss whether continuous-dosing SSRIs or short-term hospitalisation are needed.
• Onset or severe worsening after childbirth — arrange a same-week assessment with a perinatal psychiatrist, because postpartum PMDD can overlap with postpartum depression and needs urgent specialist input.
• PMDD plus a personal or family history of bipolar disorder — do not start SSRIs without psychiatric supervision, because they can occasionally trigger a manic episode in vulnerable women; the safer first step is a psychiatrist, not a pharmacy.

• Myth: PMDD is just bad PMS. Fact: PMDD is a distinct DSM-5 depressive disorder affecting 3 to 8 percent of women (versus the roughly 75 percent who have some PMS), severe enough to derail work, marriage and parenting in ways PMS never does.
• Myth: PMDD is mental weakness or attention-seeking. Fact: PMDD is a neurochemical condition in which the brain's serotonin system responds abnormally to the normal estrogen and progesterone shifts of the cycle; the woman is no more responsible for it than for asthma or thyroid disease.
• Myth: PMDD will go away after marriage or after a baby. Fact: PMDD often persists across the reproductive years, can flare postpartum and again in perimenopause, and only reliably resolves at menopause; treatment is the right answer, not waiting.
• Myth: Only Western women get PMDD. Fact: PMDD is a biological condition that exists at the same prevalence globally; it is simply diagnosed more often where awareness is higher, and dismissed or mislabelled elsewhere.
• Myth: Birth control alone will fix everything. Fact: drospirenone-containing pills help some women, particularly with physical and some mood symptoms, but they are not first line for everyone; many women need an SSRI, CBT or both alongside (or instead of) the pill. The diary plus the doctor decides.

• American Psychiatric Association — DSM-5-TR: Premenstrual Dysphoric Disorder
• ACOG — Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD)
• NHS — Premenstrual syndrome (PMS)
• Office on Women's Health (US HHS) — Premenstrual dysphoric disorder (PMDD)
• Ministry of Health and Family Welfare — Tele MANAS (National Tele Mental Health Programme)
• NIMHANS — National Institute of Mental Health and Neurosciences